Windtree Therapeutics News

10-Q: Quarterly report

May 16 05:06

S-1: General form for registration of securities under the Securities Act of 1933

May 9 20:42

8-K: Current report

Apr 24 05:17

EFFECT: Others

Apr 22 18:10

8-K: Current report

Apr 20 04:58

CORRESP: CORRESP

Apr 18 10:19

S-3/A: Registration statement for specified transactions by certain issuers (Amendment)

Apr 18 05:05

8-K: Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates

Apr 17 19:34

10-K: Annual report

Apr 17 05:21

Windtree Therapeutics | 8-K: Current report

Apr 11 04:38

Windtree Therapeutics | 8-K: Current report

Apr 9 04:38

Windtree Therapeutics | NT 10-K: Others

Apr 3 05:31

Windtree Therapeutics | DEF 14A: Definitive information statements

Mar 13 05:14

UPLOAD: Others

Feb 21 11:16

Windtree Therapeutics | 8-K: Current report

Feb 17 06:12

Windtree Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Feb 15 06:28

Windtree Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lincoln Park Capital Fund, LLC(6.181%),Lincoln Park Capital, LLC(6.181%), etc.

Feb 15 05:33

Windtree Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(5.3%),Lind Global Partners II LLC(5.3%), etc.

Feb 14 09:21

Windtree Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Feb 13 05:45

Windtree Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deerfield Mgmt, L.P.(7.59%),Deerfield Management Company, L.P.(7.59%), etc.

Feb 2 06:28